• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效 CRISPR 诱导人血液干细胞中的 t(9;11)染色体易位和急性白血病。

High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells.

机构信息

Department of Pathology.

Bass Center for Childhood Cancer and Blood Disorders, Department of Pediatrics.

出版信息

Blood Adv. 2019 Oct 8;3(19):2825-2835. doi: 10.1182/bloodadvances.2019000450.

DOI:10.1182/bloodadvances.2019000450
PMID:31582391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6784514/
Abstract

Chromosomal rearrangements involving the mixed lineage leukemia () gene, also known as , are often observed in human leukemias and are generally associated with a poor prognosis. To model these leukemias, we applied clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 gene editing to induce chromosomal rearrangements in human hematopoietic stem and progenitor cells purified from umbilical cord blood. Electroporation of ribonucleoprotein complexes containing chemically modified synthetic single guide RNAs and purified Cas9 protein induced translocations between chromosomes 9 and 11 [t(9;11)] at an efficiency >1%. Transplantation of gene-edited cells into immune-compromised mice rapidly induced acute leukemias of different lineages and often with multiclonal origins dictated by the duration of in vitro culture prior to transplantation. Breakpoint junction sequences served as biomarkers to monitor clonal selection and progression in culture and in vivo. High-dimensional cell surface and intracellular protein analysis by mass cytometry (CyTOF) revealed that gene-edited leukemias recapitulated disease-specific protein expression observed in human patients and showed that -rearranged () mixed phenotype acute leukemias (MPALs) were more similar to acute myeloid leukemias (AMLs) than to acute lymphoblastic leukemias (ALLs). Therefore, highly efficient generation of chromosomal translocations in primary human blood stem cells using CRISPR/Cas9 reliably models human acute leukemia and provides an experimental platform for basic and translational studies of leukemia biology and therapeutics.

摘要

涉及混合谱系白血病()基因的染色体重排,也称为,在人类白血病中经常观察到,通常与预后不良有关。为了模拟这些白血病,我们应用成簇规律间隔短回文重复(CRISPR)/Cas9 基因编辑在从脐带血中纯化的人类造血干祖细胞中诱导染色体重排。包含化学修饰的合成单指导 RNA 和纯化的 Cas9 蛋白的核糖核蛋白复合物的电穿孔诱导 9 号和 11 号染色体之间的易位 [t(9;11)],效率>1%。基因编辑细胞移植到免疫缺陷小鼠中迅速诱导不同谱系的急性白血病,并且通常具有多克隆起源,这取决于移植前体外培养的时间。断点连接序列作为生物标志物,用于监测体外和体内培养中的克隆选择和进展。通过质谱流式细胞术(CyTOF)进行的高维细胞表面和细胞内蛋白质分析表明,基因编辑的白血病再现了人类患者中观察到的疾病特异性蛋白质表达,并表明 -重排()混合表型急性白血病(MPAL)与急性髓细胞性白血病(AML)比急性淋巴细胞性白血病(ALL)更相似。因此,使用 CRISPR/Cas9 在原代人类血液干细胞中高效产生染色体易位可靠地模拟人类急性白血病,并为白血病生物学和治疗学的基础和转化研究提供了实验平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e7/6784514/2269057705ea/advancesADV2019000450absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e7/6784514/2269057705ea/advancesADV2019000450absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44e7/6784514/2269057705ea/advancesADV2019000450absf1.jpg

相似文献

1
High-efficiency CRISPR induction of t(9;11) chromosomal translocations and acute leukemias in human blood stem cells.高效 CRISPR 诱导人血液干细胞中的 t(9;11)染色体易位和急性白血病。
Blood Adv. 2019 Oct 8;3(19):2825-2835. doi: 10.1182/bloodadvances.2019000450.
2
CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.CRISPR 基因编辑小鼠血液干细胞和祖细胞诱导 MLL-AF9 染色体易位和 MLL-AF9 白血病发生。
Int J Mol Sci. 2020 Jun 15;21(12):4266. doi: 10.3390/ijms21124266.
3
leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.利用基因组编辑技术在人造血干细胞中诱导 t(9;11)染色体易位所致白血病。
Blood Adv. 2018 Apr 24;2(8):832-845. doi: 10.1182/bloodadvances.2017013748.
4
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.伴有11q23染色体易位的急性淋巴细胞白血病和急性髓细胞白血病中MLL基因的重排。
N Engl J Med. 1993 Sep 23;329(13):909-14. doi: 10.1056/NEJM199309233291302.
5
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells .CRISPR-Cas9 诱导的 t(11;19)/MLL-ENL 易位导致人类造血祖细胞白血病的发生。
Haematologica. 2017 Sep;102(9):1558-1566. doi: 10.3324/haematol.2017.164046. Epub 2017 Jun 1.
6
Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.JMJD1C 结构域在 MLL 重排白血病中的关键作用。
Blood Adv. 2019 May 14;3(9):1499-1511. doi: 10.1182/bloodadvances.2018026054.
7
-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?伴有 t(4;11)(q21;q23)的重排急性白血病——当前的治疗选择。嵌合抗原受体 T 细胞(CAR-T)疗法是否有作用?
Cells. 2019 Oct 29;8(11):1341. doi: 10.3390/cells8111341.
8
MLL leukemia induction by genome editing of human CD34+ hematopoietic cells.通过对人类CD34+造血细胞进行基因组编辑诱导MLL白血病
Blood. 2015 Oct 1;126(14):1683-94. doi: 10.1182/blood-2015-05-646398. Epub 2015 Aug 26.
9
Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia.脑膜瘤 1 对于混合谱系白血病重排的急性髓系白血病是不可或缺的。
Haematologica. 2020 May;105(5):1294-1305. doi: 10.3324/haematol.2018.211201. Epub 2019 Aug 14.
10
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.ZNF521 通过改变基因表达图谱增强 MLL-AF9 依赖性急性髓系白血病中的造血干细胞转化。
Int J Mol Sci. 2021 Oct 6;22(19):10814. doi: 10.3390/ijms221910814.

引用本文的文献

1
Pbx3-mediated suppression of type I interferon response contributes to leukemia progression driven by MLL-AF9.Pbx3介导的I型干扰素反应抑制促进了由MLL-AF9驱动的白血病进展。
Cancer Gene Ther. 2025 Apr;32(4):475-485. doi: 10.1038/s41417-025-00888-7. Epub 2025 Mar 19.
2
Only Infant -Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib.仅婴儿重排型白血病对沃拉替尼抑制波罗样激酶1(PLK-1)敏感。
Int J Mol Sci. 2024 Nov 27;25(23):12760. doi: 10.3390/ijms252312760.
3
The epigenetic state of the cell of origin defines mechanisms of leukemogenesis.

本文引用的文献

1
Gene correction for SCID-X1 in long-term hematopoietic stem cells.X 连锁重症联合免疫缺陷病 1 型的基因矫正:长期造血干细胞。
Nat Commun. 2019 Apr 9;10(1):1634. doi: 10.1038/s41467-019-09614-y.
2
Dimensionality reduction for visualizing single-cell data using UMAP.使用UMAP进行单细胞数据可视化的降维方法。
Nat Biotechnol. 2018 Dec 3. doi: 10.1038/nbt.4314.
3
The genetic basis and cell of origin of mixed phenotype acute leukaemia.混合表型急性白血病的遗传基础和细胞起源。
细胞起源的表观遗传状态决定白血病发生的机制。
Leukemia. 2025 Jan;39(1):87-97. doi: 10.1038/s41375-024-02428-y. Epub 2024 Oct 1.
4
Three-dimensional chromatin landscapes in MLLr AML.MLLr急性髓系白血病中的三维染色质景观
Exp Hematol Oncol. 2024 May 22;13(1):56. doi: 10.1186/s40164-024-00523-5.
5
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia.表观遗传调节因子EP300/CREBBP是MLL重排急性髓系白血病中很有前景的治疗靶点。
Cell Death Discov. 2024 May 1;10(1):206. doi: 10.1038/s41420-024-01940-5.
6
Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion.基因组编辑诱导的 t(4;11)染色体易位模型伴有 KMT2A-AFF1 融合的 B 细胞前体急性淋巴细胞白血病。
J Clin Invest. 2024 Jan 2;134(1):e171030. doi: 10.1172/JCI171030.
7
Droplet Digital PCR for Oncogenic KMT2A Fusion Detection.液滴数字 PCR 检测致癌性 KMT2A 融合。
J Mol Diagn. 2023 Dec;25(12):898-906. doi: 10.1016/j.jmoldx.2023.09.006. Epub 2023 Oct 7.
8
Progress and Prospects of Gene Editing in Pluripotent Stem Cells.多能干细胞基因编辑的进展与展望
Biomedicines. 2023 Aug 1;11(8):2168. doi: 10.3390/biomedicines11082168.
9
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation.不依赖造血干细胞(HSC)的祖细胞易受Mll-Af9诱导的白血病转化影响。
Cancers (Basel). 2023 Jul 14;15(14):3624. doi: 10.3390/cancers15143624.
10
Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells.增强子重塑驱动白血病干细胞中 MLL 癌基因依赖性转录失调。
Blood Adv. 2023 Jun 13;7(11):2504-2519. doi: 10.1182/bloodadvances.2022008787.
Nature. 2018 Oct;562(7727):373-379. doi: 10.1038/s41586-018-0436-0. Epub 2018 Sep 12.
4
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34 Hematopoietic Stem and Progenitor Cells.CD34 造血干/祖细胞中基于 CRISPR/Cas9-AAV6 的基因组编辑的全球转录反应。
Mol Ther. 2018 Oct 3;26(10):2431-2442. doi: 10.1016/j.ymthe.2018.06.002. Epub 2018 Jul 11.
5
leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing.利用基因组编辑技术在人造血干细胞中诱导 t(9;11)染色体易位所致白血病。
Blood Adv. 2018 Apr 24;2(8):832-845. doi: 10.1182/bloodadvances.2017013748.
6
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse.在诊断时对 B 细胞前体急性淋巴细胞白血病进行单细胞发育分类,揭示了复发的预测因子。
Nat Med. 2018 May;24(4):474-483. doi: 10.1038/nm.4505. Epub 2018 Mar 5.
7
CRISPR/Cas9 genome editing in human hematopoietic stem cells.CRISPR/Cas9 基因组编辑在人类造血干细胞中的应用。
Nat Protoc. 2018 Feb;13(2):358-376. doi: 10.1038/nprot.2017.143. Epub 2018 Jan 25.
8
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.利用 CRISPR/Cas9 和 AAV6 对人造血干/祖细胞进行多重基因工程改造。
Elife. 2017 Sep 28;6:e27873. doi: 10.7554/eLife.27873.
9
The MLL recombinome of acute leukemias in 2017.2017 年急性白血病的 MLL 重排组。
Leukemia. 2018 Feb;32(2):273-284. doi: 10.1038/leu.2017.213. Epub 2017 Jul 13.
10
MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches.MLL重排白血病——科学与临床治疗方法的最新进展
Front Pediatr. 2017 Feb 9;5:4. doi: 10.3389/fped.2017.00004. eCollection 2017.